General Oncology Taps Abid Ansari as New CFO to Lead Financial Strategy
Company - People | Apr 08, 2025 | EIN
General Oncology, a clinical-stage biopharmaceutical company, has appointed Abid Ansari as its new Chief Financial Officer. Ansari, with over 20 years in the biotech industry, is known for his expertise in financial strategy and corporate development. His past roles include significant capital-raising activities and business development transactions, such as mergers and acquisitions, IPOs, and in-licensing deals. CEO Jeff Glazier highlighted Ansari's potential to strengthen the company's financial foundation as they advance a promising pipeline, including potential pivotal trials and clinical developments. Ansari's rich experience heralds vital support for General Oncology's mission to deliver innovative therapies targeting metastatic cancers.
Sectors
- Biotechnology
- Pharmaceutical
Geography
- United States – General Oncology is based in Boston, Massachusetts, and Abid Ansari is a Certified Public Accountant in Delaware.
Industry
- Biotechnology – The article discusses General Oncology, a biopharmaceutical company in the biotech sector, focusing on developing treatments for metastatic cancers.
- Pharmaceutical – General Oncology's core operation involves the development of innovative therapies, which aligns with the pharmaceutical industry.
Financials
- $450M – Total equity transactions managed by Abid Ansari in his career.
- $153M – Series C funding raised by Ansari at Artios.
- $146M – IPO led by Ansari at Precision BioSciences.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| General Oncology, Inc. | Target Company | Company | A clinical-stage biopharmaceutical company pioneering first-in-class medicines for metastatic cancers. |
| Abid Ansari | Chief Financial Officer | Person | Newly appointed CFO of General Oncology with over 20 years of experience in financial strategy and corporate development. |
| Jeff Glazier | Chief Executive Officer | Person | CEO of General Oncology, overseeing corporate strategy and operations. |
| Artios | Former employer | Company | Biotechnology company where Ansari raised a $153M Series C funding. |
| Precision BioSciences | Former employer | Company | Biotechnology company where Ansari led a $146M IPO. |